Lantern Pharma ( (LTRN) ) just unveiled an update.
On November 7, 2024, the Company hosted a conference call and live webinar to discuss its third-quarter financial results, utilizing a presentation to assist the discussions. This information is part of a Current Report but is not considered filed under the Securities Exchange Act of 1934, meaning it doesn’t carry certain legal liabilities.
For an in-depth examination of LTRN stock, go to TipRanks’ Stock Analysis page.
